Liminatus Pharma,…
USUSDLiminatus Pharma, Inc. Class A Common Stock (US:LIMN) — Biotechnology: Biological Products (No Diagnostic Substances). Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om virksomheden
- Websted
- liminatuspharma.com
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Hovedkontor
- CERRITOS, United States
- Administrerende direktør
- Chris Kim
- Ansatte
- 1
- Udestående aktier
- 67.16 mio. pr. 2026-08-14
- Free float
- 919 251
- Markedsværdi
- 5.01 mio. USD
- Insidere
- 33.75%
- Institutionelle investorer
- 1.41%
- Branche (SIC)
- Biological Products, (No Diagnostic Substances)
- FCF
- −9.98 mio. USD
- Gæld
- 1.44 mio. USD
- Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse
Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
Børser og tickere
| Børs | Ticker | Valuta | Pris | Type |
|---|---|---|---|---|
| US USA Stocks | LIMN | USD | 3.69 -4.90% | almindelige aktier |
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
annonce
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Cygnus Capital Advisors,… | 0.49% | 6 587 | 2026-06-30 |
| Xtx Topco Ltd | 0.33% | 4 437 | 2026-06-30 |
| Geode Capital Management… | 0.21% | 2 768 | 2026-06-30 |
| Fidelity Concord Street… | 0.18% | 2 409 | 2026-07-31 |
| Citadel Advisors Llc | 0.08% | 1 122 | 2026-06-30 |
| Vanguard Capital Managem… | 0.08% | 1 009 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.08% | 1 009 | 2026-06-30 |
| Goldman Sachs Group Inc | 0.06% | 804 | 2026-06-30 |
| Stonex Group Inc. | 0.04% | 521 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.03% | 460 | 2026-06-30 |
| State Street Corporation | 0.03% | 380 | 2026-06-30 |
| UBS Group AG | 0.02% | 335 | 2026-06-30 |
| Fidelity Concord Street… | 0.01% | 162 | 2026-07-31 |
| Fidelity Concord Street… | 0.01% | 124 | 2026-07-31 |
